We found that T2DM enhanced gut leakage in T2DM mice infected with Mtb and that recombinant IL-22 treatment prevented this permeability and maintained the integrity of the intestinal barrier (Fig 6). This evidence concerns the gene IL22 and type 2 diabetes mellitus.